260 related articles for article (PubMed ID: 30243414)
21. Can nebulized naloxone be used safely and effectively by emergency medical services for suspected opioid overdose?
Weber JM; Tataris KL; Hoffman JD; Aks SE; Mycyk MB
Prehosp Emerg Care; 2012; 16(2):289-92. PubMed ID: 22191727
[TBL] [Abstract][Full Text] [Related]
22. Opioid overdose education and naloxone distribution: Development of the Veterans Health Administration's national program.
Oliva EM; Christopher MLD; Wells D; Bounthavong M; Harvey M; Himstreet J; Emmendorfer T; Valentino M; Franchi M; Goodman F; Trafton JA;
J Am Pharm Assoc (2003); 2017; 57(2S):S168-S179.e4. PubMed ID: 28292502
[TBL] [Abstract][Full Text] [Related]
23. Reversal of Pediatric Opioid Toxicity with Take-Home Naloxone: a Case Report.
Lebin JA; Chen BC; Valento MJ
J Med Toxicol; 2019 Apr; 15(2):134-135. PubMed ID: 30632074
[TBL] [Abstract][Full Text] [Related]
24. The role of take-home naloxone in the epidemic of opioid overdose involving illicitly manufactured fentanyl and its analogs.
Kim HK; Connors NJ; Mazer-Amirshahi ME
Expert Opin Drug Saf; 2019 Jun; 18(6):465-475. PubMed ID: 31033357
[TBL] [Abstract][Full Text] [Related]
25. Adoption and Utilization of an Emergency Department Naloxone Distribution and Peer Recovery Coach Consultation Program.
Samuels EA; Baird J; Yang ES; Mello MJ
Acad Emerg Med; 2019 Feb; 26(2):160-173. PubMed ID: 30074673
[TBL] [Abstract][Full Text] [Related]
26. The feasibility of employing a home healthcare model for education and treatment of opioid overdose using a naloxone auto-injector in a private practice pain medicine clinic.
Dragovich A; Brason F; Beltran T; McCoart A; Plunkett AR
Curr Med Res Opin; 2018 Dec; 34(12):2137-2141. PubMed ID: 29667452
[TBL] [Abstract][Full Text] [Related]
27. Take-home naloxone treatment for opioid emergencies: a comparison of routes of administration and associated delivery systems.
Elzey MJ; Fudin J; Edwards ES
Expert Opin Drug Deliv; 2017 Sep; 14(9):1045-1058. PubMed ID: 27606669
[TBL] [Abstract][Full Text] [Related]
28. Naloxone prescribing: room for finesse.
Gilham J; Lloyd G
Br J Hosp Med (Lond); 2019 Mar; 80(3):C46-C48. PubMed ID: 30860915
[No Abstract] [Full Text] [Related]
29. Emergency Nurse Perceptions of Naloxone Distribution in the Emergency Department.
Punches BE; Soliman S; Freiermuth CE; Lane BH; Lyons MS
J Emerg Nurs; 2020 Sep; 46(5):675-681.e1. PubMed ID: 32828483
[TBL] [Abstract][Full Text] [Related]
30. How competent are people who use opioids at responding to overdoses? Qualitative analyses of actions and decisions taken during overdose emergencies.
Neale J; Brown C; Campbell ANC; Jones JD; Metz VE; Strang J; Comer SD
Addiction; 2019 Apr; 114(4):708-718. PubMed ID: 30476356
[TBL] [Abstract][Full Text] [Related]
31. Heroin overdose resuscitation with naloxone: patient uses own prescribed supply to save the life of a peer.
Winston I; McDonald R; Tas B; Strang J
BMJ Case Rep; 2015 Sep; 2015():. PubMed ID: 26370638
[TBL] [Abstract][Full Text] [Related]
32. Comparison of rates of opioid withdrawal symptoms and reversal of opioid toxicity in patients treated with two naloxone dosing regimens: a retrospective cohort study.
Purssell R; Godwin J; Moe J; Buxton J; Crabtree A; Kestler A; DeWitt C; Scheuermeyer F; Erdelyi S; Balshaw R; Rowe A; Cochrane CK; Ng B; Jiang A; Risi A; Ho V; Brubacher JR
Clin Toxicol (Phila); 2021 Jan; 59(1):38-46. PubMed ID: 32401548
[TBL] [Abstract][Full Text] [Related]
33. Intranasal Naloxone Administration.
Ortega R; Nozari A; Baker W; Surani S; Edwards M
N Engl J Med; 2021 Mar; 384(12):e44. PubMed ID: 33761209
[No Abstract] [Full Text] [Related]
34. Characteristics of Patients With Opioid Use Disorder Associated With Performing Overdose Reversals in the Community: An Opioid Treatment Program Analysis.
Katzman JG; Greenberg NH; Takeda MY; Moya Balasch M
J Addict Med; 2019; 13(2):131-138. PubMed ID: 30303890
[TBL] [Abstract][Full Text] [Related]
35. Intranasal Naloxone for Opioid Overdose.
Taylor JL; Lasser KE
JAMA; 2024 Jan; 331(3):250-251. PubMed ID: 38127361
[TBL] [Abstract][Full Text] [Related]
36. Naloxone (Narcan) nasal spray for opioid overdose.
Med Lett Drugs Ther; 2016 Jan; 58(1485):1-2. PubMed ID: 26714239
[No Abstract] [Full Text] [Related]
37. Expanding access to naloxone in the United States.
Doyon S; Aks SE; Schaeffer S; ; ;
Clin Toxicol (Phila); 2014 Dec; 52(10):989-92. PubMed ID: 25283253
[No Abstract] [Full Text] [Related]
38. Naloxone nasal spray.
Drug Ther Bull; 2019 Sep; 57(9):137-140. PubMed ID: 31296655
[No Abstract] [Full Text] [Related]
39. Are take-home naloxone programmes effective? Systematic review utilizing application of the Bradford Hill criteria.
McDonald R; Strang J
Addiction; 2016 Jul; 111(7):1177-87. PubMed ID: 27028542
[TBL] [Abstract][Full Text] [Related]
40. Emergency department physicians' and pharmacists' perspectives on take-home naloxone.
Holland TJ; Penm J; Dinh M; Aran S; Chaar B
Drug Alcohol Rev; 2019 Feb; 38(2):169-176. PubMed ID: 30697852
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
